Medically reviewed by Matthew Wosnitzer, MD Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Kevin P. Martin Jr. was shocked to learn he had stage 4 prostate cancer at 61. The endurance athlete has vowed to stay active ...

New research shows distant-stage prostate cancer increased 6.7% annually across California between 2011 and 2021, while mortality rates have plateaued since 2012 after years of decline.

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

Radiotherapy remains a fundamental treatment for prostate cancer, and recent developments in precision medicine and ...

New research shows distant-stage prostate cancer increased 6.7% annually across California between 2011 and 2021, while mortality rates have plateaued since 2012 after years of decline.

Medically reviewed by Jamin Brahmbhatt, MD The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves ...